|
|
Volumn 101, Issue 7, 2009, Pages 444-445
|
|
Assessing the HPV vaccine: Researchers confront complex interplay of factors
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
WART VIRUS VACCINE;
HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18;
CANCER EPIDEMIOLOGY;
CANCER IMMUNIZATION;
CANCER INCIDENCE;
CANCER PREVENTION;
HUMAN;
NOTE;
PRECANCER;
PRIORITY JOURNAL;
UTERINE CERVIX CANCER;
VIRUS INFECTION;
WART VIRUS;
ADOLESCENT;
ADULT;
ALPHAPAPILLOMAVIRUS;
CANCER INVASION;
CARCINOMA IN SITU;
DEVELOPING COUNTRY;
DRUG APPROVAL;
DRUG DESIGN;
FEMALE;
FOOD AND DRUG ADMINISTRATION;
GENETICS;
HEALTH CARE PLANNING;
HEALTH SURVEY;
IMMUNOLOGY;
MASS SCREENING;
ORGANIZATION AND MANAGEMENT;
PATHOLOGY;
POVERTY;
REGISTER;
UNITED STATES;
UTERINE CERVIX TUMOR;
VIROLOGY;
ADOLESCENT;
ADULT;
ALPHAPAPILLOMAVIRUS;
CARCINOMA IN SITU;
DEVELOPING COUNTRIES;
DRUG APPROVAL;
DRUG DESIGN;
FEMALE;
HUMANS;
MASS SCREENING;
MEDICALLY UNDERSERVED AREA;
NEOPLASM INVASIVENESS;
NEW MEXICO;
PAPILLOMAVIRUS INFECTIONS;
PAPILLOMAVIRUS VACCINES;
POPULATION SURVEILLANCE;
POVERTY;
REGISTRIES;
TUMOR VIRUS INFECTIONS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
UTERINE CERVICAL NEOPLASMS;
YOUNG ADULT;
|
|
EID: 63649141918
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djp074 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|